(Q35889928)

10 August 2017

Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening (English)

1 reference

colorectal cancer screening

10 August 2017

0 references

1 reference

1 reference

1 reference

4

1 reference

10 August 2017

U Haug

2

0 references

author name string

S Tao

series ordinal

1

1 reference

10 August 2017

K Kuhn

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

27 March 2012

1 reference

British Journal of Cancer

10 August 2017

1 reference

10 August 2017

106

1 reference

10 August 2017

8

1 reference

10 August 2017

1424-1430

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2012.104

10 August 2017

0 references

cites work

Protection from colorectal cancer after colonoscopy: a population-based, case-control study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Low-dose aspirin use and performance of immunochemical fecal occult blood tests

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Sensitivity estimates of blood-based tests for colorectal cancer detection: impact of overrepresentation of advanced stage disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Blood markers for early detection of colorectal cancer: a systematic review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Does a negative screening colonoscopy ever need to be repeated?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Sex differences in performance of fecal occult blood testing

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326680

Case-Control Study Supports Extension of Surveillance Interval After Colonoscopic Polypectomy to at Least 5 Yr

24 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.104

Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.104

Quantitative Immunochemical Fecal Occult Blood Testing for Colorectal Adenoma Detection: Evaluation in the Target Population of Screening and Comparison With Qualitative Tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.104

Efficacy and tolerability of split-dose magnesium citrate: low-volume (2 liters) polyethylene glycol vs. single- or split-dose polyethylene glycol bowel preparation for morning colonoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.104

Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening

21 January 2018

1 reference

12 December 2020

A combination of serum markers for the early detection of colorectal cancer

1 reference

12 December 2020

Assessment of novel combinations of biomarkers for the detection of colorectal cancer

1 reference

12 December 2020

Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer

1 reference

12 December 2020

Plasma TIMP-1 in patients with colorectal adenomas: a prospective study

1 reference

12 December 2020

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2012.104

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

PubMed publication ID

22454079

1 reference